| Literature DB >> 34916559 |
Severine P Parois1,2, Susan D Eicher3, Stephen R Lindemann4, Jeremy N Marchant3.
Abstract
The influence of feed supplements on behavior and memory has been recently studied in livestock. The objectives of the study were to evaluate the effects of a synbiotic on: an episodic-like (SOR: Spontaneous Object Recognition), a working (BARR: Fence barrier task), a long-term (TMAZE: Spatial T-maze task) memory test and on gut microbiota composition. Eighteen female piglets were supplemented from 1 to 28 days of age with a synbiotic (SYN), while 17 served as control (CTL). Feces were collected on days 16, 33 and 41 for 16S rRNA gene composition analyses. In the SOR, SYN piglets interacted more quickly with the novel object than CTL piglets. In the BARR, SYN piglets had shorter distances to finish the test in trial 3. In the TMAZE, SYN piglets were quicker to succeed on specific days and tended to try the new rewarded arm earlier during the reversal stage. Difference of microbiota composition between treatments was nonexistent on D16, a tendency on D33 and significant on D41. The synbiotic supplement may confer memory advantages in different cognitive tasks, regardless of the nature of the reward and the memory request. Difference in memory abilities can potentially be explained by differences in microbiota composition.Entities:
Mesh:
Year: 2021 PMID: 34916559 PMCID: PMC8677727 DOI: 10.1038/s41598-021-03565-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic of the device used for the barrier test (BARR), with the tested pig starting on the opposite side of the two companion piglets.
Numbers, means, SE of untransformed traits in the SOR (Spontaneous Object Recognition), the BARR (Fence barrier task) and the TMAZE (Spatial T-maze task) for Controls (5 ml TruMoo® Chocolate—Whole milk) and Synbiotic (3 strains of Lactobacillus at 109 CFU/piglet, fructo-oligosaccharide at 10 mg/day/piglet, beta-glucan at 11 mg/day/piglet, vitamin C at 10 mg/day/piglet diluted in 5 ml of chocolate milk) treated piglets.
| Test | TraitsA | Trial or day | Controls | Synbiotics | Treatment | Trial/day | Treatment × trial/day | ||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean ± SE | N | Mean ± SE | p value | p value | p value | |||
| SOR | Lat. to interact with the old object (s) | 14 | 283 ± 38.8 | 13 | 201 ± 34.9 | 0.13 | |||
| Total Dur. of interaction with the old object (s) | 18 | 14.6 ± 3.7 | 17 | 20.7 ± 5.2 | 0.34 | ||||
| Lat. to interact with the new object (s) | 16 | 255 ± 30b | 14 | 165 ± 31a | 0.046 | ||||
| Total Dur. of interaction with the new object (s) | 18 | 27.3 ± 7.0 | 17 | 27.4 ± 6.1 | 0.99 | ||||
| Freq. in the zone of the old object (n) | 18 | 4.0 ± 1.2a | 17 | 7.8 ± 1.2b | 0.030 | ||||
| Freq. in the zone of the new object (n) | 18 | 5.2 ± 1.2 | 17 | 7.6 ± 1.2 | 0.16 | ||||
| Discriminant Index | 17 | 0.30 ± 0.13 | 14 | 0.22 ± 0.14 | 0.69 | ||||
| BARR | Total distance travelled (m) | 1 | 16 | 11.9 ± 1.6 | 15 | 9.7 ± 1.4 | 0.16 | < 0.0001 | 0.027 |
| 2 | 16 | 6.4 ± 1.3 | 16 | 6.3 ± 0.6 | |||||
| 3 | 16 | 7.4 ± 1.2b | 15 | 4.2 ± 0.3a | |||||
| 4 | 17 | 5.3 ± 0.7 | 15 | 3.8 ± 0.2 | |||||
| 5 | 17 | 4.7 ± 0.5 | 16 | 4.9 ± 0.8 | |||||
| Lat. to cross the 1st hole (s) | 1a | 16 | 61.9 ± 8.9 | 16 | 67.3 ± 10.4 | 0.82 | < 0.0001 | 0.43 | |
| 2b | 15 | 15.0 ± 1.9 | 16 | 24.9 ± 4.3 | |||||
| 3b | 16 | 27.9 ± 8.5 | 16 | 18.0 ± 3.3 | |||||
| 4b | 17 | 25.8 ± 7.4 | 16 | 29.4 ± 15.1 | |||||
| 5b | 17 | 22.3 ± 5.1 | 16 | 25.3 ± 6.5 | |||||
| Trial duration (s) | 1a | 15 | 96.3 ± 17.6 | 14 | 93.3 ± 12.2 | 0.78 | < 0.0001 | 0.23 | |
| 2b | 15 | 25.1 ± 2.8 | 16 | 37.4 ± 4.5 | |||||
| 3b | 15 | 40.2 ± 9.4 | 15 | 25.1 ± 2.5 | |||||
| 4b | 16 | 38.1 ± 10.3 | 15 | 23.3 ± 3.7 | |||||
| 5b | 17 | 30.8 ± 5.3 | 16 | 36.7 ± 11.4 | |||||
| TMAZE | Mean duration to touch the rewarded bowl (s) | A1v | 13 | 52.3 ± 9.6 | 11 | 48.3 ± 7.9 | 0.12 | < 0.0001 | 0.33 |
| A2v | 13 | 40.1 ± 7.5 | 11 | 47.6 ± 6.1 | |||||
| A3u | 12 | 24.3 ± 5.6b | 11 | 13.0 ± 1.9a | |||||
| A4u | 12 | 13.2 ± 2.0 | 11 | 17.4 ± 2.3 | |||||
| A5u | 13 | 11.9 ± 1.4 | 11 | 14.1 ± 2.5 | |||||
| A6u | 13 | 15.9 ± 3.3 | 11 | 13.9 ± 2.3 | |||||
| R1z | 7 | 30.1 ± 7.4 | 7 | 22.9 ± 3.7 | |||||
| R2y | 8 | 12.2 ± 2.5 | 9 | 18.5 ± 3.1 | |||||
| R3y | 10 | 12.9 ± 3.0 | 9 | 19.8 ± 4.4 | |||||
| First trial to try the new rewarded arm (n) | R1–3 | 13 | 19.8 ± 4.3t | 11 | 10.3 ± 3.3s | 0.048 | |||
| First two successive trials during the reversal stage (n) | R1–3 | 13 | 23.7 ± 3.9 | 11 | 17.7 ± 3.9 | 0.19 | |||
Statistical models used: (1) traits from the SOR test: a linear model Y ~ Treatment; (2) traits from the BARR test: a linear mixed model for repeated variables Y ~ Treament + Trial + Treatment × Trial + (1|pig); (3) traits from the TMAZE test: for durations, a linear mixed models for repeated variables Y ~ Treament + Day + Treatment × Day + (1|pig) and, for number of trials generalized linear mixed model following a Poisson law Y ~ Treatment + (1|side of the reward).
Letters were attributed per test in alphabetical order for significantly different values (p < 0.05), regarding both the trial/day and the treatment effect. Discriminant Index: (DN1: Duration interacting with the novel object − DO3: Duration interaction with the old object)/(DN1 + DO3). Lat: Latency; Freq: Frequency; Dur: Duration.
AA3 to A6: days 3 to 6 during the acquisition stage of the test; R1 to R3: days 1 to 3 during the reversal stage of the test.
Figure 2Cognitive performances of the pigs of the two treatment diets (CTL: Controls, 5 ml TruMoo® Chocolate—Whole milk versus SYN: Synbiotics, 3 strains of Lactobacillus at 109 CFU/piglet, fructo-oligosaccharide at 10 mg/day/piglet, beta-glucan at 11 mg/day/piglet, vitamin C at 10 mg/day/piglet diluted in 5 ml of chocolate milk). 1Letters differ at p < 0.05 between days; *p < 0.05. 2A: trials during the acquisition phase; R: trials during the reversal phase.
α-diversity indicators of the microbiota in feces samples, at three different days (D16, D33 and D41) after the beginning of two different treatment diets: Controls (5 ml TruMoo® Chocolate—Whole milk) versus Synbiotic (3 strains of Lactobacillus at 109 CFU/piglet, fructo-oligosaccharide at 10 mg/day/piglet, beta-glucan at 11 mg/day/piglet, vitamin C at 10 mg/day/piglet diluted in 5 ml of chocolate milk).
| Traits | Treatment | Day | |||||
|---|---|---|---|---|---|---|---|
| Controls | Synbiotics | p value | 16 | 33 | 41 | p value | |
| Chao1 estimator | 246.2 ± 7.6 | 248.1 ± 7.8 | > 0.1 | 184.7 ± 8.7a | 295.2 ± 9.6b | 261.5 ± 9.8b | 1.4e−12 |
| ACE estimator | 292.6 ± 9.4 | 299.9 ± 9.6 | > 0.1 | 211.9 ± 10.8a | 359.9 ± 11.9c | 316.9 ± 12.2b | 4.4e−14 |
| Shannon index | 3.91 ± 0.06 | 3.90 ± 0.06 | > 0.1 | 3.70 ± 0.07a | 4.16 ± 0.08b | 3.86 ± 0.08a | 1.0e−04 |
| Simpson index | 0.050 ± 0.004 | 0.050 ± 0.004 | > 0.1 | 0.053 ± 0.005a | 0.037 ± 0.005a | 0.058 ± 0.005b | 0.013 |
| Inverse Simpson index | 27.3 ± 2.0 | 26.1 ± 2.1 | > 0.1 | 23.4 ± 2.3a | 32.8 ± 2.6b | 23.7 ± 2.6a | 0.015 |
| Species observed | 151.9 ± 4.8 | 151.9 ± 5.0 | > 0.1 | 118.7 ± 5.6a | 176.7 ± 6.2b | 160.4 ± 6.3b | 1.4e−9 |
| Coverage (%) | 99.1 ± 0.2 | 98.9 ± 0.2 | > 0.1 | 99.4 ± 0.2 | 99.0 ± 0.2 | 98.7 ± 0.2 | 0.072 |
Statistical linear model formula: Trait ~ Treatment + Time. Letters were attributed for significantly different values a < b < c.
Adjusted means ± SEM.
Figure 3Relative abundances of genera for the two supplementation treatments (CTL: Controls, versus SYN: Synbiotics) on three days of sampling (D16, D33 and D41). Genera outside the 25 most abundant are combined as “Other.”
Figure 4β-diversity of gut communities with respect to supplementation treatments and day of sampling. Distances were calculated using the Yue and Clayton theta metric and plotted using PCoA for the two supplementation treatments (CTL: Controls versus SYN: Synbiotics) on three day of sampling (D16, D33 and D41).
Figure 5Linear discriminant analysis of taxa differentiating the pigs of the two supplementation treatments (CTL: Controls versus SYN: Synbiotics) on three day of sampling (D16, D33 and D41). Taxa with LDA scores > 3.5 as computed via LEfSe are plotted on the cladograms. Unclassified taxa are referenced as “uncl.”
Effects of two different treatment diets (CTL: Controls, 5 ml TruMoo® Chocolate—Whole milk versus SYN: Synbiotics, 3 strains of Lactobacillus at 109 CFU/piglet, fructo-oligosaccharide at 10 mg/day/piglet, beta-glucan at 11 mg/day/piglet, vitamin C at 10 mg/day/piglet diluted in 5 ml of chocolate milk) and day of sampling (D16, D33 and D41) on 16S rRNA gene microbiota composition.
| Treatment × day | p value | Bacteria taxa for significant treatment × day interactions ( | ||||
|---|---|---|---|---|---|---|
| CTL | 16 | SYN | 16 | NS | ||
| CTL | 33 | SYN | 33 | 0.066 | ||
| CTL | 41 | SYN | 41 | 0.047 | CTL_D41 > SYN_D41 CTL_D41 > SYN_D41 CTL_D41 > SYN_D41 | |
| CTL | 16 | CTL | 33 | < 0.001 | CTL_D16 > CTL_D33 CTLD16 < CTL_D33 CTL_D16 > CTL_D33 CTL_D16 > CTL_D33 CTLD16 < CTL_D33 CTL_D16 > CTL_D33 CTL_D16 > CTL_D33 | |
| CTL | 16 | CTL | 41 | < 0.001 | CTL_D16 > CTL_D41 CTL_D16 < CTL_D41 CTL_D16 > CTL_D41 CTL_D16 > CTL_D41 CTL_D16 > CTL_D41 CTL_D16 < CTL_D41 CTL_D16 > CTL_D41 | |
| CTL | 33 | CTL | 41 | 0.012 | CTL_D33 < CTL_D41 CTL_D33 < CTL_D41 CTL_D33 > CTL_D41 CTL_D33 > CTL_D41 CTL_D33 < CTL_D41 CTL_D33 < CTL_D41 CTL_D33 < CTL_D41 | |
| SYN | 16 | SYN | 33 | < 0.001 | SYN_D16 > SYN_D33 SYN_D16 < SYN_D33 SYN_D16 > SYN_D33 SYN_D16 < SYN_D33 SYN_D16 < SYN_D33 SYN_D16 > SYN_D33 SYN_D16 < SYN_D33 | |
| SYN | 16 | SYN | 41 | < 0.001 | SYN_D16 > SYN-D41 SYN_D16 < SYN_D41 SYN_D16 > SYN-D41 SYN_D16 < SYN_D41 SYN_D16 > SYN-D41 SYN_D16 < SYN_D41 | |
| SYN | 33 | SYN | 41 | 0.025 | SYN_D33 < SYN_D41 SYN_D33 > SYN_D41 | |
Analysis of molecular variance (AMOVA) using the standardized distance matrix method in mothur adjusted by using Bonferroni correction. The determination of the bacteria responsible for the AMOVA significant differences were analyzed with the command “metastats" in mothur from the mothur standard operating procedure (SOP) designed for MiSeq data[17]. The mothur MiSeq SOP was accessed in August 2018.
aBacterial taxa mentioned had a p-value below 0.001.